Ashfield Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Ashfield Capital Partners's LLY Position: Q3 2022 in Review
Ashfield Capital Partners reduced its Eli Lilly (LLY) stake by 0.9% in Q3 2022, selling an estimated $22.2K and leaving 7,740 shares worth $2.5M. The position accounts for 0.21% of the portfolio, ranked #84.
Ashfield Capital Partners first reported a position in LLY in Q1 2017 and has held it in 21 quarters since. The position peaked at $2.53M in Q2 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Ashfield Capital Partners held 7,740 shares of Eli Lilly worth $2.5M as of Q3 2022.
- Ashfield Capital Partners sold 70 Eli Lilly shares in Q3 2022, an estimated $22.2K.
- Eli Lilly made up 0.21% of Ashfield Capital Partners's portfolio in Q3 2022, its #84 holding.
- Ashfield Capital Partners first reported a position in Eli Lilly in Q1 2017 and has held it in 21 quarters since.
- Ashfield Capital Partners's Eli Lilly position peaked at $2.53M in Q2 2022.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Ashfield Capital Partners's 13F filing for Q3 2022, filed 10 Nov 2022.